Endocrine control of growth

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 163, Issue 2, 2013, Pages 76-85

  Murray, Philip G ^a,b   Clayton, Peter E ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Growth; Growth hormone; IGF 1; Puberty

Indexed keywords

CORTICOSTEROID; GHRELIN; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR; KISSPEPTIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOSTATIN; TACHYKININ; TESTOSTERONE; THYROID HORMONE; VITAMIN D;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BODY HEIGHT; BONE DENSITY; BREAST DEVELOPMENT; CATCH UP GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CHILDHOOD; CROWN RUMP LENGTH; ENDOCRINE FUNCTION; FETUS GROWTH; GENETIC TRANSCRIPTION; GROWTH ACCELERATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH PLATE; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANCY; LIVER; MUSCLE STRENGTH; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PUBERTY; SECOND TRIMESTER PREGNANCY; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TESTIS DEVELOPMENT; THIRD TRIMESTER PREGNANCY;

EID: 85027949136     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.31357     Document Type: Article

References (80)

1. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB. 1999. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-4987.
2. Avioli LV. 1993. Glucocorticoid effects on statural growth. Br J Rheumatol 32:27-30.
3. Baker J, Liu JP, Robertson EJ, Efstratiadis A. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82.
4. Baron J, Huang Z, Oerter KE, Bacher JD, Cutler GB Jr. 1992. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol 263:E489-E492.
5. Baron J, Klein KO, Colli MJ, Yanovski JA, Novosad JA, Bacher JD, Cutler GB Jr. 1994. Catch-up growth after glucocorticoid excess: A mechanism intrinsic to the growth plate. Endocrinology 135:1367-1371.
6. Baumann G. 2001. Growth hormone binding protein 2001. J Pediatr Endocrinol Metab 14:355-375.
7. Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT. 2001. The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: An important but forgotten component of the circulating IGF system. J Endocrinol 170:63-70.
8. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. 1997. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407.
9. Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, Bouhours-Nouet N, Voinot C, Audran M, Limal JM. 2004. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. J Clin Endocrinol Metab 89:6185-6192.
10. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, Puffenberger EG, Hamosh A, Nanthakumar EJ, Curristin SM, et al. 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337339.
11. Domene HM, Hwa V, Argente J, Wit JM, Camacho-Hubner C, Jasper HG, Pozo J, van Duyvenvoorde HA, Yakar S, Fofanova-Gambetti OV, Rosenfeld RG, International ALS Collaborative Group. 2009. Human acid-labile subunit deficiency: Clinical, endocrine and metabolic consequences. Horm Res 72:129-141.
12. Donohue MM, Demay MB. 2002. Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 143:3691-3694.
13. Douglas J, Hanks S, Temple IK, Davies S, Murray A, Upadhyaya M, Tomkins S, Hughes HE, Cole TR, Rahman N. 2003. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 72:132-143.
14. Dupont J, Dunn SE, Barrett JC, LeRoith D. 2003. Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog Horm Res 58:325-342.
15. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S. 2002. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103.
16. Gevers EF, Wit JM, Robinson IC. 1996. Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat. Endocrinology 137:1013-1018.
17. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM. 2002. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res 17:1408-1419.
18. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK. 2005. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289:E266-E271.
19. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Nechine I, Le Bouc Y. 2005. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 37:1003-1007.
20. Giustina A, Scalvini T, Tassi C, Desenzani P, Poiesi C, Wehrenberg WB, Rogol AD, Veldhuis JD. 1997. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab 82:1210-1219.
21. Gluckman PD, Johnson-Barrett JJ, Butler JH, Edgar BW, Gunn TR. 1983. Studies of insulin-like growth factor-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 19:405-413.
22. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M. 2002. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988.
23. Hanson D, Murray PG, O'Sullivan J, Urquhart J, Daly S, Bhaskar SS, Biesecker LG, Skae M, Smith C, Cole T, Kirk J, Chandler K, Kingston H, Donnai D, Clayton PE, Black GC. 2011. Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth. Am J Hum Genet 89:148-153.
24. Hanson D, Murray PG, Coulson T, Sud A, Omokanye A, Stratta E, Sakhinia F, Bonshek C, Wilson LC, Wakeling E, Temtamy SA, Aglan M, Rosser EM, Mansour S, Carcavilla A, Nampoothiri S, Khan WI, Banerjee I, Chandler KE, Black GC, Clayton PE. 2012. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J Mol Endocrinol 49:267-275.
25. Hindmarsh PC, Matthews DR, Brook CG. 1988. Growth hormone secretion in children determined by time series analysis. Clin Endocrinol (Oxf) 29:35-44.
26. Hindmarsh PC, Fall CH, Pringle PJ, Osmond C, Brook CG. 1997. Peak and trough growth hormone concentrations have different associations with the insulin-like growth factor axis, body composition, and metabolic parameters. J Clin Endocrinol Metab 82:2172-2176.
27. Hsueh AJ, Erickson GF. 1978. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids 32:639-648.
28. Huber C, Dias-Santagata D, Glaser A, O'Sullivan J, Brauner R, Wu K, Xu X, Pearce K, Wang R, Uzielli ML, Dagoneau N, Chemaitilly W, Superti-Furga A, Dos Santos H, Mégarbané A, Morin G, Gillessen-Kaesbach G, Hennekam R, Van der Burgt I, Black GC, Clayton PE, Read A, Le Merrer M, Scambler PJ, Munnich A, Pan ZQ, Winter R, Cormier-Daire V. 2005. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet 37:1119-1124.
29. Hwa V, Nadeau K, Wit JM, Rosenfeld RG. 2011. STAT5b deficiency: Lessons from STAT5b gene mutations. Best Pract Res Clin Endocrinol Metab 25:61-75.
30. Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M. 2004. Ghrelin, appetite, and gastric motility: The emerging role of the stomach as an endocrine organ. FASEB J 18:439-456.
31. Ioan D, Dumitriu L, Belengeanu V, Bistriceanu M, Maximilian C. 1988. Leprechaunism: Report of two cases and review. Endocrinologie 26:205-209.
32. Jux C, Leiber K, Hugel U, Blum W, Ohlsson C, Klaus G, Mehls O. 1998. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139:3296-3305.
33. Kallijarvi J, Lahtinen U, Hamalainen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE. 2005. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res 308:146-155.
34. Kamischke A, Kemper DE, Castel MA, Luthke M, Rolf C, Behre HM, Magnussen H, Nieschlag E. 1998. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 11:41-45.
35. Karlberg J, Engstrom I, Karlberg P, Fryer JG. 1987. Analysis of linear growth using a mathematical model. I. From birth to three years. Acta Paediatr Scand 76:478-488.
36. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER. 1993. Androgen-stimulated pubertal growth: The effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 76:996-1001.
37. Kindblom JM, Gothe S, Forrest D, Tornell J, Tornell J, Vennstrom B, Ohlsson C. 2001. GH substitution reverses the growth phenotype but not the defective ossification in thyroid hormone receptor alpha 1-/-beta-/- mice. J Endocrinol 171:15-22.
38. Klingseisen A, Jackson AP. 2011. Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev 25:2011-2024.
39. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660.
40. Lanning NJ, Carter-Su C. 2006. Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225-235.
41. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. 1991. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219-225.
42. Leger J, Czernichow P. 1989. Congenital hypothyroidism: Decreased growth velocity in the first weeks of life. Biol Neonate 55:218-223.
43. Lewis UJ, Dunn JT, Bonewald LF, Seavey BK, Vanderlaan WP. 1978. A naturally occurring structural variant of human growth hormone. J Biol Chem 253:2679-2687.
44. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
45. Liu JL, Yakar S, LeRoith D. 2000. Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system. Proc Soc Exp Biol Med 223:344-351.
46. Masuda N, Watahiki M, Tanaka M, Yamakawa M, Shimizu K, Nagai J, Nakashima K. 1988. Molecular cloning of cDNA encoding 20kDa variant human growth hormone and the alternative splicing mechanism. Biochim Biophys Acta 949:125-131.
47. Meinhardt UJ, Ho KK. 2006. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf) 65:413-422.
48. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908.
49. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. 1995. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698.
50. Navarro VM. 2012. New insights into the control of pulsatile GnRH release: The role of Kiss1/neurokinin B neurons. Front Endocrinol (Lausanne) 3:48.
51. Niall HD, Hogan ML, Sauer R, Rosenblum IY, Greenwood FC. 1971. Sequences of pituitary and placental lactogenic and growth hormones: Evolution from a primordial peptide by gene reduplication. Proc Natl Acad Sci USA 68:866-870.
52. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 33:497-501.
53. Oldham S, Hafen E. 2003. Insulin/IGF and target of rapamycin signaling: A TOR de force in growth control. Trends Cell Biol 13:79-85.
54. Osorio M, Torres J, Moya F, Pezzullo J, Salafia C, Baxter R, Schwander J, Fant M. 1996. Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: Relationships to fetoplacental growth at term. Early Hum Dev 46:15-26.
55. Panetta R, Patel YC. 1995. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 56:333-342.
56. Pantelakis SN, Sinaniotis CA, Sbirakis S, Ikkos D, Doxiadis SA. 1972. Night and day growth hormone levels during treatment with corticosteroids and corticotrophin. Arch Dis Child 47:605-608.
57. Persson M, Pasupathy D, Hanson U, Norman M. 2011. Birth size distribution in 3, 705 infants born to mothers with type 1 diabetes: A population-based study. Diabetes Care 34:1145-1149.
58. Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, Ekici AB, van Essen AJ, Goecke TO, Al-Gazali L, Chrzanowska KH, Zweier C, Brunner HG, Becker K, Curry CJ, Dallapiccola B, Devriendt K, Dörfler A, Kinning E, Megarbane A, Meinecke P, Semple RK, Spranger S, Toutain A, Trembath RC, Voss E, Wilson L, Hennekam R, de Zegher F, Dörr HG, Reis A. 2008. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science 319:816-819.
59. Ren SG, Malozowski S, Sanchez P, Sweet DE, Loriaux DL, Cassorla F. 1989. Direct administration of testosterone increases rat tibial epiphyseal growth plate width. Acta Endocrinol (Copenh) 121:401-405.
60. Roa J, Navarro VM, Tena-Sempere M. 2011. Kisspeptins in reproductive biology: Consensus knowledge and recent developments. Biol Reprod 85:650-660.
61. Roth CL, Ojeda SR. 2005. Genes involved in the neuroendocrine control of normal puberty and abnormal puberty of central origin. Pediatr Endocrinol Rev 3:67-76.
62. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH. 2003. The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627.
63. Silvestrini G, Ballanti P, Patacchioli FR, Mocetti P, Di Grezia R, Wedard BM, Angelucci L, Bonucci E. 2000. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 26:33-42.
64. Skinner AM, Price DA, Addison GM, Clayton PE, Mackay RI, Soo A, Mui CY. 1992. The influence of age, size, pubertal status and renal factors on urinary growth hormone excretion in normal children and adolescents. Growth Regul 2:156-160.
65. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. 1994. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061.
66. Sparago A, Cerrato F, Vernucci M, Ferrero GB, Silengo MC, Riccio A. 2004. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nat Genet 36:958-960.
67. Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR. 2000. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 15:2431-2442.
68. Storr HL, Chan LF, Grossman AB, Savage MO. 2007. Paediatric Cushing's syndrome: Epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 18:167-174.
69. Strous GJ, dos Santos CA, Gent J, Govers R, Sachse M, Schantl J, van Kerkhof P. 2004. Ubiquitin system-dependent regulation of growth hormone receptor signal transduction. Curr Top Microbiol Immunol 286:81-118.
70. Tanner JM. 1963. Regulation of growth in size in mammals. Nature 199:845-850.
71. Tanner J. 1978. Fetus into man: Physical growth from conception to maturity. Cambridge, MA: Harvard University Press.
72. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK. 2009. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 41:354-358.
73. Tsaneva-Atanasova K, Sherman A, van Goor F, Stojilkovic SS. 2007. Mechanism of spontaneous and receptor-controlled electrical activity in pituitary somatotrophs: Experiments and theory. J Neurophysiol 98:131-144.
74. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM. 1997. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414-3420.
75. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. 1993. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: Correlations with birth weight. Am J Obstet Gynecol 169:89-97.
76. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA. 2006. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230.
77. Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J. 2001. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 98:6871-6876.
78. Weissberger AJ, Ho KK. 1993. Activation of the somatotropic axis by testosterone in adult males: Evidence for the role of aromatization. J Clin Endocrinol Metab 76:1407-1412.
79. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. 1996. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367.
80. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D. 2002. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781.